NASDAQ: FBIO
Fortress Biotech Inc Stock Ownership - Who owns Fortress Biotech?

Insider buying vs selling

Have Fortress Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David JinChief Financial Officer2025-04-015,000$1.22
$6.08kBuy
David JinChief Financial Officer2024-10-012,625$1.23
$3.22kBuy
Lindsay A. Md RosenwaldPRESIDENT CEO CHAIRMAN2024-09-23763,359$1.84
$1.40MBuy

1 of 1

FBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FBIO insiders and whales buy or sell their stock.

FBIO Shareholders

What type of owners hold Fortress Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lindsay A. Md Rosenwald22.25%6,579,083$12.43MInsider
Elliott Associates LP7.02%2,076,381$3.92MInsider
Michael S. Weiss6.09%1,801,138$3.40MInsider
Elliott International LP5.60%1,654,898$3.13MInsider
David Jin4.21%1,245,893$2.35MInsider
Cambridge Investment Research Advisors Inc3.40%1,004,365$1.90MInstitution
Vanguard Group Inc2.54%752,551$1.42MInstitution
George Avgerinos2.22%655,170$1.24MInsider
Pvg Asset Management Corp1.60%472,221$892.50kInstitution
Nantahala Capital Management LLC1.10%325,520$615.23kInstitution

1 of 3

FBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FBIO16.61%50.90%Net Buying
SER0.84%99.16%Net BuyingNet Buying
HOWL47.80%52.20%Net BuyingNet Buying
ATHE0.00%0.00%
VRCA37.48%62.52%Net Selling

Fortress Biotech Stock Ownership FAQ

Who owns Fortress Biotech?

Fortress Biotech (NASDAQ: FBIO) is owned by 16.61% institutional shareholders, 50.90% Fortress Biotech insiders, and 32.48% retail investors. Lindsay A. Md Rosenwald is the largest individual Fortress Biotech shareholder, owning 6.58M shares representing 22.25% of the company. Lindsay A. Md Rosenwald's Fortress Biotech shares are currently valued at $12.11M.

If you're new to stock investing, here's how to buy Fortress Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.